Hosted by: MATTER

October 27, 2019: 9:00am – 12:00pm

One day a doctor will reach out to you before you even know you’re sick. Care will shift away from the episodic, reactive and impersonal healthcare paradigm we have today to a model that is continuous, predictive and holistic.

In the not-too-distant future, patients will have a completely different dialogue with their healthcare providers, using digital technologies to diagnose and manage disease in a more precise, experiential and continuous fashion. Healthcare will be increasingly delivered outside of acute care settings, with a focus on comprehensive care and wellness that may change the need for traditional pharmaceutical therapies. Precision health tools, new payment models, and consumer demand for therapies that seamlessly deliver a better patient experience will converge to force life sciences companies to rethink and adjust their value proposition — or be left behind.

Life sciences companies that are able to succeed in this new reality have already begun working to implement a culture of intrapreneurship and a practice of innovation that explores novel collaborations with payers, health systems and entrepreneurs. They are harnessing the power of these partnerships and are building upon their current capabilities to define and deliver new avenues of value for the future. Join MATTER in this session to learn what’s at stake for the pharmaceutical and life sciences industry, and hear directly from pharma innovators on how they are experimenting with new models to ensure they remain relevant tomorrow.

Agenda

9:00 – 9:05am: Check-in

9:05 – 9:15am: Welcome – Steven Collens, CEO MATTER

9:15 – 9:30am: The Time for Innovation is Now
Emily Tower, Partner, Life Sciences, CapGemini

9:30 – 10:30am: The Practice of Innovation: Reprogramming Corporate
Executives to Create a Culture of Entrepreneurship – Fireside Chat w/ Jeffrey Stewart, President, U.S. Commercial Operations, Abbvie

10:30 – 11:00am: Start-up Spotlight: Fireside Chat w/ Dave Ormesher, CEO
Closerlook and PhysIQ & rMARK Bio

11:00 – 11:55am: Beyond the Mothership: Collaborating with External
Innovators
Fireside Chat w/ Kenneth Stromdahl, Sr. Vice President, Device R&D, Novo Nordisk

11:55am – 12:00pm: Wrap-up